Assembly Biosciences, Inc. (ASMB)
28.34
+1.84
(+6.94%)
USD |
NASDAQ |
May 22, 16:00
28.32
-0.02
(-0.07%)
After-Hours: 20:00
Assembly Biosciences EPS Diluted (Quarterly) : -0.5372 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.612 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.079M |
| Revenue (Quarterly) | 8.213M |
| Total Expenses (Quarterly) | 17.29M |
| Enterprise Value | 226.29M |
| Gross Profit Margin (Quarterly) | 99.68% |
| Profit Margin (Quarterly) | -110.5% |
| Earnings Yield | -4.24% |
| Normalized Earnings Yield | -4.238 |